首都医科大学学报 ›› 2016, Vol. 37 ›› Issue (3): 341-345.doi: 10.3969/j.issn.1006-7795.2016.03.017

• 乳腺微创外科 • 上一篇    下一篇

乳腔镜辅助保留NAC乳腺癌改良根治术并假体植入Ⅰ期成形的临床研究

崔智淼, 骆成玉, 李鑫, 刘宝胤, 丁毅   

  1. 首都医科大学附属复兴医院普外科, 北京 100038
  • 收稿日期:2016-03-25 出版日期:2016-06-21 发布日期:2016-06-13
  • 通讯作者: 骆成玉 E-mail:luochengyu@163.com

Clinical application of nipple areola complex sparing modified mastoscopic mastectomy with one-stage reconstruction

Cui Zhimiao, Luo Chengyu, Li Xin, Liu Baoyin, Ding Yi   

  1. Department of General Surgery, Fuxing Hospital, Capital Medical University, Beijing 100038, China
  • Received:2016-03-25 Online:2016-06-21 Published:2016-06-13

摘要: 目的 探讨乳腔镜辅助保留乳头乳晕复合体(nipple areola complex,NAC)改良根治术并假体植入Ⅰ期成形治疗早期乳腺癌的安全性和可行性。方法 将2012年至2015年间于首都医科大学附属复兴医院治疗的46例乳腺癌患者,按照患者意愿分别行乳腔镜辅助保留NAC改良根治术并假体植入Ⅰ期成形(实验组,23例)及乳腔镜辅助保留NAC乳腺癌改良根治术(对照组,23例)。比较两组手术时间、术中出血量、清扫淋巴结个数、引流量、引流时间、术后合并症、复发率、转移率以及术后外观评价。结果 两组患者手术时间、术中出血量、清扫淋巴结个数、引流量、引流时间比较,差异无统计学意义(均P >0.05)。两组患者均获得随访,均无观察到术后合并症、复发及转移。两组患者术后外观评价满意率(95.65% vs 65.22%),组间比较差异有统计学意义(P <0.05)。结论 乳腔镜辅助保留NAC改良根治术并假体植入Ⅰ期成形治疗早期乳腺癌安全、可行,美容效果、术后患者满意度明显优于乳腔镜辅助保留NAC乳腺癌改良根治术。

关键词: 乳腺癌, 乳腔镜, 改良根治术, Ⅰ期成形, 假体植入

Abstract: Objective To investigate the safety and feasibility of the nipple areola complex (NAC) sparing modified radical mastoscopic mastectomy with one-stage reconstruction in treatment of early stage breast cancer. Methods From March 2012 to November 2015, a total of 46 breast cancer cases, according to their own choice, received NAC sparing mastoscopic modified radical mastectomy with one-stage reconstruction (experiment group, 23 cases),or NAC sparing mastoscopic modified radical mastectomy (control group, 23 cases), respectively. The operative time, operative blood loss, lymph node harvested, drainage flow, drainage duration, complication, recurrence, metastasis and postoperative appearance evaluation were compared between the two groups. Results The operative time, operative blood loss, lymph node harvested, drainage flow, drainage duration showed no statistically significant difference between the two groups (P >0.05). All the cases were followed up, there were no postoperative complications, recurrences and metastasis observed. The postoperative appearance evaluation satisfactory rates (95.65% vs 65.22%)in experiment group was significantly higher than that of control group (P <0.05). Conclusion NAC sparing mastoscopic mastectomy with one-stage reconstruction is safe and feasible for early breast cancer, and cosmetic effect and postoperative satisfactory rate is significantly superior to NAC sparing mastoscopic modified radical mastectomy.

Key words: breast cancer, mastoscopy, modified radical mastectomy, one-stage reconstruction, prosthesis implantation

中图分类号: